Grp78 as a therapeutic target for refractory head-neck cancer with CD24- CD44+ stemness phenotype

C. C. Chiu, L. Y. Lee, Y. C. Li, Y. J. Chen, Y. C. Lu, Y. L. Li, H. M. Wang, J. T. Chang, A. J. Cheng

Research output: Contribution to journalArticlepeer-review

47 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Grp78 as a therapeutic target for refractory head-neck cancer with CD24- CD44+ stemness phenotype'. Together they form a unique fingerprint.

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology